Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

30
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
30
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

552
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
552
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

25
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
25
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

899
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
899
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

340
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
340

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms for Long-term Retention of Plutonium in the Respiratory Tract: Inferences from Animal and Human Studies.

Health physics·2026
Same author

EURADOS/REMPAN Review on Monitoring and Dosimetry for Radionuclide-contaminated Wounds.

Disaster medicine and public health preparedness·2025
Same author

Dose Coefficients and Reference Bioassay Functions for Intakes of Radionuclides via Contaminated Wounds Using the ICRP OIR Models.

Health physics·2025
Same author

Chelation Modeling of a Plutonium-238 Inhalation Incident Treated with Delayed DTPA.

Radiation research·2023
Same author

Modified human respiratory tract model to describe the retention of plutonium in scar tissues.

Radiation protection dosimetry·2023
Same author

Practical overview of the ICRP Publication 145 phantoms for use with MCNP.

Radiation protection dosimetry·2023

Related Experiment Video

Updated: May 28, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.0K

Likelihood Functions for Bioassay Measurements for Development, Selection, and Calibration of Biokinetic Models.

John Klumpp1, Deepesh Poudel

  • 1Los Alamos National Laboratory, Los Alamos, NM.

Health Physics
|February 14, 2025
PubMed
Summary

Internal dosimetrists need correct likelihood functions for bioassay measurements to accurately estimate radiation doses from incorporated radionuclides. This toolkit provides essential functions for interpreting bioassay data and improving internal dosimetry accuracy.

Keywords:
biokineticsdosimetry, internalmonitoring, biological factorsradiation dose

More Related Videos

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.1K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

20.6K

Related Experiment Videos

Last Updated: May 28, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.0K
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.1K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

20.6K

Area of Science:

  • Radiation Protection
  • Nuclear Science
  • Biokinetics

Background:

  • Internal dosimetrists require accurate biokinetic models for radiation dose calculation.
  • Bioassay measurements are crucial for assessing internal radionuclide contamination.
  • Likelihood functions are essential for interpreting bioassay data.

Purpose of the Study:

  • To describe correct likelihood functions for various bioassay measurements.
  • To provide a practical toolkit for internal dosimetrists.
  • To ensure accurate interpretation of bioassay data for dose estimation.

Main Methods:

  • Identification and description of appropriate likelihood functions for bioassay data.
  • Explanation of how to apply these likelihood functions in internal dosimetry.
  • Compilation of a comprehensive set of likelihood functions for common use cases.

Main Results:

  • A comprehensive guide to likelihood functions for diverse bioassay measurements is presented.
  • The paper details the application of these functions for accurate dose assessment.
  • The provided functions cover the majority of scenarios encountered in internal dosimetry.

Conclusions:

  • Using the correct likelihood functions is critical for accurate internal dose estimation.
  • This paper serves as a valuable resource for academic and occupational dosimetrists.
  • The toolkit enhances the reliability of interpreting bioassay measurements in radiation protection.